Jung‐Hui Sun - Concepedia

Author

Jung‐Hui Sun

Bristol-Myers Squibb (United States)

Also Known As

Jung-Hui Sun, Jung‐Hui Sun

Publications

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)DuPont (United States)Wilmington University Experimental Station

About

Jung‐Hui Sun is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	5	5	381
2	Medicine	4	4	280
3	Biochemistry	4	4	368
4	Biomolecular Engineering	4	4	361
5	Engineering	2	2	151

Jung‐Hui Sun

Publications

970

Citations

H-Index

Page 1

	Year	Citations
Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine Lawrence W. Fitzgerald, Timothy C. Burn, Barry S. Brown, Molecular Pharmacology	2000	428
Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-<i>N</i>-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1<i>H</i>-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor Mimi L. Quan, Patrick Y. S. Lam, Qi Han, Journal of Medicinal Chemistry Pharmaceutical SciencePharmacotherapyPharmaceutical ChemistryMolecular PharmacologyMedicinal Chemistry	2004	188
Efficient Synthesis of 5-(Bromomethyl)- and 5-(Aminomethyl)-1-THP-Indazole Jung‐Hui Sun, Christopher A. Teleha, Jia-Sheng Yan, The Journal of Organic Chemistry Medicinal ChemistryDiversity Oriented SynthesisEngineeringBiochemistryDonut Icon	1997	127
Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase Robert G. Gentles, Min Ding, John A. Bender, Journal of Medicinal Chemistry	2014	98
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms Honghe Wan, Gretchen M. Schroeder, Amy C. Hart, ACS Medicinal Chemistry Letters Hematological MalignancyMedicinal ChemistryNovel TherapyMedicineImmunology	2015	39
Beyond U0126. Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors John Wityak, Frank W. Hobbs, Daniel S. Gardner, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryNatural SciencesMedicine	2004	31
A New Synthesis of Aminomalononitrile Tosylate Edward C. Taylor, Jung‐Hui Sun Synthesis EngineeringOrganic ChemistryAminomalononitrile TosylateSynthetic ChemistryEnantioselective Synthesis	1980	24
Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups James R. Corte, Donald Pinto, Tianan Fang, Journal of Medicinal Chemistry PharmacotherapyPharmaceutical ChemistryDrug ResistanceMolecular PharmacologyMedicinal Chemistry	2019	22
The synthesis and antitumor evaluation of unsymmetrical bis-imides Robert J. Cherney, Stephen G. Swartz, Arthur D. Patten, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNatural SciencesAntitumor EvaluationChemistryPharmacology	1997	13

Page 1